telehealth.helpFind my match

Home WikiTelehealth Insurance & cost

Prior authorization

From WikiTelehealth, the telehealth.help reference · Last updated

Prior authorization is a process in which a health plan must approve a drug or service before it agrees to pay for it. Health plans that cover GLP-1 medicines for weight loss usually ask for prior authorization, and the Medicare GLP-1 Bridge requires it.

Prior authorization
Also calledPreauthorization, PA
Requested byPrescriber
Decided byHealth plan or PBM
Common forGLP-1 medicines, specialty drugs
Federal ruleCMS-0057-F (medical items, 2026)

How it works

In a prior authorization request, the prescriber sends the health plan information showing that the patient meets the plan's rules for a drug. For GLP-1 medicines, plans often ask for a diagnosis, a recent BMI, weight-related conditions and records of earlier treatment. The plan or its pharmacy benefit manager then approves or denies the request.

Approval is often time-limited. Many plans require a renewal request after several months, which may ask for proof of weight loss or continued use.

Prior authorization is often paired with other utilization rules. Step therapy requires a patient to try a lower-cost drug first. Quantity limits cap how much of a drug the plan will pay for in a period. A drug must also be on the plan's formulary to be covered at all.

Regulation

The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) set decision deadlines starting in 2026 for Medicare Advantage, Medicaid and CHIP plans: 72 hours for urgent requests and 7 calendar days for standard requests. Those deadlines apply to medical items and services, not to drugs. In 2026 CMS proposed a separate rule that would set deadlines for drug prior authorization.

Prior authorization and GLP-1 medicines

Employer and individual plans decide whether to cover GLP-1 medicines for weight loss, and many cover them only for type 2 diabetes. Medicare law has long excluded drugs used for weight loss from Part D. Under the Medicare GLP-1 Bridge, which runs from July 1, 2026 through December 31, 2027, Part D enrollees who meet clinical criteria can get selected GLP-1 medicines for weight reduction, and the prescriber must submit a prior authorization request.

People whose plan denies coverage, or who have no drug coverage, can pay without insurance. Options are compared on the without insurance page. How to check whether a plan covers Wegovy or Zepbound, and what to do after a denial, is on the insurance coverage page. Some online programs file the request for the patient: Ro checks coverage and handles prior authorization for brand-name Ozempic, Wegovy and Zepbound pens, and others are listed under online programs that work with insurance.

Check GLP-1 coverage, or compare programs without PA

See also

References

  1. CMS: Interoperability and Prior Authorization Final Rule (CMS-0057-F) fact sheet. cms.gov
  2. CMS: Medicare GLP-1 Bridge. cms.gov
  3. KFF: What to know about the BALANCE model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge (May 11, 2026). kff.org

Last updated . Category: Insurance & cost. Browse all 38 WikiTelehealth entries.